Journal articleEur J Med Chem2019

Rad51/BRCA2 disruptors inhibit homologous recombination and synergize with olaparib in pancreatic cancer cells.

DOI 10.1016/j.ejmech.2019.01.008 ↗ OpenAlex, retrieved 5 November 2026

Journal: Eur J Med Chem
Published: 10 January 2019
Citations: 45
Type: Article

These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try